Doug Brown stepped into the CEO role at Amai Proteins on September 1, 2026, bringing a career built across DSM Nutritional Products, Clasado Biosciences, and Sirio Pharma/Best Formulations. The appointment signals a deliberate pivot from R&D-led leadership toward commercial scale — a transition pattern common among precision-fermentation startups that have cleared proof-of-concept and need to convert pipeline interest into supply agreements.
Brown's background is specifically relevant to the channels Amai is chasing. His tenure as Chief Commercial Officer and Head of Global Account Management at Sirio Pharma and Best Formulations puts him squarely in the dietary supplement contract manufacturing world, while earlier work in nutritional lipids at DSM gives him credibility inside large CPG ingredient procurement teams. For food and beverage operators evaluating alternative sweetener sourcing, that contact network matters more than the technology credentials.
Why Formulators Are Watching
sweelin® is a monellin-derived sweet protein produced through precision fermentation — the same production method behind a growing class of animal-free dairy and flavor ingredients now entering retail and foodservice supply chains. At roughly 3,000 times the sweetness intensity of sugar on a weight basis, it competes on dosage economics with high-intensity sweeteners like stevia and monk fruit, while offering a protein-based label declaration that reads better in clean-ingredient briefs. Amai claims the ingredient enables up to 70.0% sugar reduction without taste or cost compromise, which, if validated at scale, addresses one of the primary reformulation objections buyers raise when evaluating next-generation sweeteners. Operators navigating menu and beverage reformulation pressure will recognize the pitch — the hard part is always taste and line compatibility, not the sweetness number.
Brown's own framing is pointed: he references the GLP-1 and peptide era explicitly, positioning sweelin® as well-timed for a consumer cohort actively managing caloric and sugar intake under medical guidance. That is not an accident. GLP-1 drug adoption is reshaping purchase behavior across grocery, foodservice, and supplement categories, and ingredient suppliers who can credibly link their technology to that shift are finding more receptive ears in R&D and procurement meetings. For operators developing reduced-sugar SKUs or reformulating existing lines, the GLP-1 framing is increasingly a useful shorthand in buyer presentations.
Commercial Scale Still the Key Question
Outgoing CEO Dr. Amir Guttman, who navigated what the company describes as an "intense period of refocus," transitions to the Executive Board — a structure that retains technical and scientific continuity while freeing the commercial leadership lane. Precision-fermentation ingredient companies frequently use this model when moving from research-led to sales-led phases, and the dual-role structure gives Brown room to build the commercial org without losing institutional knowledge on the science side.
For procurement teams and brand formulators considering sweet protein inclusion, the practical due diligence questions remain: validated supply volumes, pricing at commercial quantities, regulatory status by market, and stability data across processing conditions. Brown's appointment accelerates the business development motion; it does not by itself answer those technical sourcing questions. Operators interested in alternative sweetener procurement and ingredient sourcing intelligence should track Amai's commercial announcements over the next two to three quarters as a proxy for where precision-fermented sweet proteins are on the readiness curve.
Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.
